机译:补体C3基因变异与已故心脏死者肾脏的肾脏移植结果的关联
Department of Surgery University Medical Center Groningen Groningen the Netherlands;
Department of Nephrology Leiden University Medical Center Leiden the Netherlands;
Department of Nephrology;
Department of Pathology and Medical Biology;
Department of Transplant Immunology;
Department of Epidemiology Unit of Genetic Epidemiology Bioinformatics University Medical Center Groningen Groningen the Netherlands;
Cardiac death donors; complement; complement component C3; deceased donor kidneys; deceased donor organs; primary graft dysfunction; renal transplantation;
机译:补体C3基因变异与已死的心脏死亡供体肾脏的肾脏移植结果相关。
机译:肾脏移植成果来自较旧的已故捐赠者:由欧洲肾协联合 - 欧洲透析和移植协会登记处的配对肾分析
机译:更新:“低温灌注装置的肾脏抗性和流速,作为影响国家肾移植研究所死者肾移植患者的结果的因素”
机译:使用顺序活体供体肾和自体干细胞移植患者对原发性(Al)淀粉样蛋白病和晚期肾功能衰竭的患者
机译:肾移植结果的回顾性分析:死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
机译:死亡者载脂蛋白L1肾病变异对肝移植结果的影响最小
机译:补体C3基因变异与已死心脏死者供肾的肾脏移植结果的关系